Pharvaris (PHVS) Total Liabilities (2019 - 2026)
Pharvaris (PHVS) posted Total Liabilities of $27.5 million for Q1 2026, down 21.84% on a QoQ basis from $35.1 million in Q4 2025, and up 14.88% year-over-year from $23.9 million in Q1 2025.
Pharvaris (PHVS) Total Liabilities (2019 - 2026) Analysis & Trends
Pharvaris' Total Liabilities history runs 8 years deep, the most recent figure standing at $27.5 million for Q1 2026.
- Quarterly Total Liabilities rose 14.88% year-over-year to $27.5 million in Q1 2026, while the trailing twelve-month figure through Mar 2026 was $27.5 million (up 14.88% YoY) and the FY2025 annual result came in at $34.1 million, up 33.41% from the prior year.
- Total Liabilities was $27.5 million for Q1 2026 at Pharvaris, down from $35.1 million in the prior quarter.
- Across five years, Total Liabilities topped out at $35.1 million in Q4 2025 and bottomed at $11.5 million in Q1 2022.
- A 5-year average of $21.6 million and a median of $20.0 million in 2024 frame the typical range for Total Liabilities.
- Annual changes were most pronounced in 2022 — Total Liabilities jumped 130.85% — and 2023, when it declined 16.39%.
- Pharvaris' Total Liabilities stood at $18.8 million in 2022, then declined by 16.39% to $15.8 million in 2023, then soared by 60.13% to $25.2 million in 2024, then jumped by 39.22% to $35.1 million in 2025, then decreased by 21.84% to $27.5 million in 2026.
- Business Quant data shows PHVS's Total Liabilities at $27.5 million in Q1 2026, $35.1 million in Q4 2025, and $31.2 million in Q3 2025.
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) | Total Liabilities (Qtr) |
|---|---|---|---|---|---|
| 1 | Oculis Holding AG | 67,072.09 Bn | 67,072.09 Bn | - | 60.46 Mn |
| 2 | Nanobiotix | 1,894.61 Bn | 1,894.55 Bn | - | 177.22 Mn |
| 3 | Akari Therapeutics | 1,014.18 Bn | 1,014.18 Bn | - | 19.51 Mn |
| 4 | BeOne Medicines | 471.64 Bn | 466.85 Bn | 1.35 Bn | 3.79 Bn |
| 5 | Vertex Pharmaceuticals | 121.72 Bn | 114.47 Bn | 2.59 Bn | 7.12 Bn |
| 6 | Regeneron Pharmaceuticals | 68.28 Bn | 59.52 Bn | 3.31 Bn | 9.45 Bn |
| 7 | Belite Bio | 61.40 Bn | 61.40 Bn | - | 15.48 Mn |
| 8 | Argenx Se | 56.94 Bn | 56.94 Bn | 1.18 Bn | - |
| 9 | Revolution Medicines | 37.37 Bn | 37.37 Bn | - | 753.82 Mn |
| 10 | Pharvaris | 2.22 Bn | 1.94 Bn | - | 27.46 Mn |
Historic Data
Download Data| Date | Value |
|---|---|
| Mar 31, 2026 | 27.46 Mn |
| Dec 31, 2025 | 35.13 Mn |
| Sep 30, 2025 | 31.16 Mn |
| Jun 30, 2025 | 28.84 Mn |
| Mar 31, 2025 | 23.90 Mn |
| Dec 31, 2024 | 25.23 Mn |
| Sep 30, 2024 | 18.00 Mn |
| Jun 30, 2024 | 20.54 Mn |
| Mar 31, 2024 | 20.02 Mn |
| Dec 31, 2023 | 15.76 Mn |
| Sep 30, 2023 | 17.65 Mn |
| Jun 30, 2023 | 17.44 Mn |
| Mar 31, 2023 | 20.02 Mn |
| Dec 31, 2022 | 18.85 Mn |
| Sep 30, 2022 | 17.96 Mn |
| Jun 30, 2022 | 17.25 Mn |
| Mar 31, 2022 | 11.50 Mn |
| Dec 31, 2021 | 8.16 Mn |
| Sep 30, 2021 | 9.04 Mn |
| Jun 30, 2021 | 9.03 Mn |